He continued as a faculty for a short period of time at Vellore in order to complete his research on adult acute lymphoblastic leukaemia and later proceeded to the United States, Houston, to pursue an additional one-year fellowship in management of leukaemias at the distinguished centre of excellence for cancer care, MD Anderson Cancer Center, till June 2016. Working with renowned experts at MD Anderson Cancer Center gave him an additional opportunity to conduct research and at the same time helped him gain insight into several newer protocols useful in the management of lymphoblastic and myeloid leukaemias.

His speciality includes managing several bleeding disorders like haemophilia (factor deficiencies), von Willebrand disease, thrombophilia (inherent ability to excessively clot), refractory anaemias, thrombocytopenia, aplastic anaemias, myelodysplasia and myeloproliferative disorders like polycythemia, thrombocytosis and myelofibrosis. He treats blood malignancies like leukaemias, multiple myelomas and lymphomas. In addition, his passion lies in conducting autologous and allogeneic bone marrow transplants in several diseases like thalassemia, aplastic anaemias, multiple myelomas, immunodeficiency disorders and several leukaemias/lymphomas.

He has joined the department of haematology/oncology and bone marrow transplant unit at Global hospitals @ Parel, Mumbai, as a hemato-Oncologist with a complete focus on the evaluation and management of both benign and malignant haematological disorders, and bone marrow transplants. Patient enquiries or referrals for the management of bleeding disorders, clotting disorders, leukaemias, lymphomas, aplastic anaemias, and patients requiring autologous or allogeneic bone marrow transplants can contact me for consultation.

He is a member of the Indian society of haematology and transfusion medicine (ISHT) and the association of physicians of India (API).

Presentations

• Clinical-biological parameters of chronic lymphocytic leukaemia: A single tertiary centre experience. Punit Jain and Vikram Mathews.Poster presentation at ISHBT 2012, Puri, Odisha, India.
• Clinical Profile of Relapsed Acute Lymphoblastic Leukaemia patients: A single-centre experience.Reshma Roshan, Punit Jain and Vikram Mathews.Poster presented at ISHBT 2013, Mumbai, India.
• The outcome of Adult Patients with Philadelphia Negative B Cell Acute Lymphoblastic Leukaemia after Frontline Therapy Failure. Punit L Jain, MD1*, Koji Sasaki, MD2, HagopKantarjian, MD3, FarhadRavandi, MD4, Jorge E. Cortes, MD5, Guillermo Garcia-Manero, MD5, Prithviraj Bose, MD6*, Naval Daver, MD7, TapanKadia, MD5, SrdanVerstovsek, MD6, Marina Konopleva, MD, PhD6, Nitin Jain, MD6, Guillermo Bravo Montalban, MD8*, Sherry Pierce, BSN, BA6* and Elias Jabbour. Abstract #85683 – ASH 2015
• Adult Acute Lymphoblastic Leukaemia: A Cost-Effective Strategy and Limitations of Intensification of Therapy in India. Punit Jain, DM*, Prashant Deshpande, MD*, Anu Korula, MD, DM*, Nisham P N, DM*, Ansu Abu Alex Sr., MSc*, Fouzia NA, DM*, Kavitha Lakshmi, MSc*, Aby Abraham, MD, DM*, Poonkuzhali Balasubramanian, M.Sc., PhD, Alok Srivastava, MD, Biju George, DM* and Vikram Mathews, DM. Abstract #84543 – ASH 2015
• Prognostic significance of the immunophenotypic composition of B cell acute lymphoblastic leukaemia at diagnosis: A novel immunophenotype-based risk score. Prashant Deshpande, Punit Jain, Ansu Abu Alex, Anu Korula, Kavitha M. Lakshmi, Nisham PN, Poonkuzhali Balasubramanian, Biju George, Vikram Mathews. Abstract – ASH 2015
• Prognostic significance of immunophenotypic risk score in childhood and adolescent B-ALL. Prashant Deshpande, Punit Jain, Ansu Abu Alex, Anu Korula, Kavitha M. Lakshmi, Nisham PN, Poonkuzhali Balasubramanian, Biju George, Vikram Mathews. Abstract – ISHBT 2015
• Profile and Clinical outcome of patients with CD10 negative Acute Lymphoblastic Leukaemia George Abraham, Punit Jain, Prashanth Deshpande, Ansu Abu Alex, Anu Korula, Nisham PN, Poonkuzhali Balasubramanian, Biju George, Vikram Mathews. Abstract – ISHBT 2015